Novel Mesothelioma Treatment Uses Electrical Fields
Oncologists in 2019 may begin offering patients with pleural mesothelioma a novel, tumor-fighting tool involving electric currents that enhance standard-of-care treatment and extend survival, according to the device manufacturer. Tumor Treating Fields (TTF) is the name of the new technology. It is designed to disrupt cancer cell division through electric fields tuned to specific frequencies. In an ongoing multicenter phase II clinical trial in Europe, TTF has shown an ability in first-line treatment to improve the effectiveness of standard chemotherapy for mesothelioma patients. The trial success has led the manufacturer t...
Source: Asbestos and Mesothelioma News - May 24, 2018 Category: Environmental Health Authors: Matt Mauney Source Type: news

Chemo Switch May Benefit PDAC: Clin Onc News Report
(MedPage Today) -- Also, is it time to consider oncoplastic surgery for breast cancer? (Source: MedPage Today Hematology/Oncology)
Source: MedPage Today Hematology/Oncology - May 24, 2018 Category: Hematology Source Type: news

Pancreatic cancer symptoms: Three early signs that could indicate you have the disease
PANCREATIC cancer symptoms usually don ’t show in the early stages, which can make it difficult to diagnose. If they do show, there are three early signs to be aware of. But to avoid the disease completely, it’s important to know what the causes of this type of cancer are. (Source: Daily Express - Health)
Source: Daily Express - Health - May 23, 2018 Category: Consumer Health News Source Type: news

RenovoRx raises $7m for drug-device pancreatic cancer therapy
RenovoRx said today that it closed a $7 million tranche in a $10 million round to fund the development of its drug-device combination product designed to deliver chemotherapy directly to tumors in patients with locally advanced pancreatic cancer. The company’s round was led by Boston Scientific (NYSE:BSX) and joined by btov Partners, Astia Angels, Golden Seeds and others. Get the full story at our sister site, Drug Delivery Business News. The post RenovoRx raises $7m for drug-device pancreatic cancer therapy appeared first on MassDevice. (Source: Mass Device)
Source: Mass Device - May 23, 2018 Category: Medical Devices Authors: Sarah Faulkner Tags: Drug-Device Combinations Food & Drug Administration (FDA) Funding Roundup Oncology Pharmaceuticals Regulatory/Compliance Vascular RenovoRx Source Type: news

Pancreatic cancer symptoms: Prevent one of the most deadly cancers by doing this
Pancreatic cancer symptoms include belly or back pain, nausea and yellowing of the eyes and skin, among others. You could prevent one of the most deadly types of cancer by losing weight, in order to maintain a healthy body weight. (Source: Daily Express - Health)
Source: Daily Express - Health - May 23, 2018 Category: Consumer Health News Source Type: news

Ovarian cancer drug shows promise in pancreatic cancer patients with BRCA mutation
A targeted therapy that has shown its power in fighting ovarian cancer in women including those with BRCA1 and BRCA2 mutations may also help patients with aggressive pancreatic cancer who harbor these mutations and have few or no other treatment options. An international team of researchers led by the Perelman School of Medicine and the Basser Center for BRCA at the University of Pennsylvania reported their findings this week in JCO Precision Oncology. (Source: World Pharma News)
Source: World Pharma News - May 18, 2018 Category: Pharmaceuticals Tags: Featured Research Research and Development Source Type: news

Improving survival in pancreatic cancer with platinum-based chemotherapy
(Johns Hopkins Medicine) A small study of adults with the most common form of pancreatic cancer adds to evidence that patients with BRCA1 or BRCA2 gene mutations long linked to a high risk of breast cancer have poorer overall survival rates than those without the mutations. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - May 17, 2018 Category: International Medicine & Public Health Source Type: news

New blood test rapidly detects signs of pancreatic cancer
(University of California - San Diego) UC San Diego researchers have developed a test that can screen for pancreatic cancer in just a drop of blood. The test, which is at the proof-of-concept stage, provides results in under an hour. It's simple: apply a drop of blood on a small electronic chip, turn the current on, wait several minutes, add fluorescent labels and look at the results under a microscope. If a blood sample tests positive for pancreatic cancer, bright fluorescent circles will appear. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - May 17, 2018 Category: Cancer & Oncology Source Type: news

Ovarian cancer drug shows promise in pancreatic cancer patients with BRCA mutation
(University of Pennsylvania School of Medicine) A targeted therapy that has shown its power in fighting ovarian cancer in women including those with BRCA1 and BRCA2 mutations may also help patients with aggressive pancreatic cancer who harbor these mutations and have few or no other treatment options. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - May 17, 2018 Category: Cancer & Oncology Source Type: news

A way to prevent pancreatic cancer from spreading post-surgery?
(Cold Spring Harbor Laboratory) New research suggests a strategy for lowering the odds of metastasis following successful pancreatic cancer surgery: The post-operative period, suggests CSHL Professor Douglas Fearon, 'offers a window during which efforts might be made to keep cortisol levels down and T cells strong so the patient's own immune system can kill the cancer cells that have made their way to other parts of the body but until this point have been dormant.' (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - May 17, 2018 Category: Cancer & Oncology Source Type: news

NIH, Northwestern scientists develop potential new approach to stop cancer metastasis
Identified compound blocks the spread of pancreatic and other cancers in various animal models. (Source: National Institutes of Health (NIH) News Releases)
Source: National Institutes of Health (NIH) News Releases - May 16, 2018 Category: American Health Source Type: news

NIH, Northwestern scientists develop potential new approach to stop cancer metastasis
(NIH/National Center for Advancing Translational Sciences (NCATS)) Researchers have identified a compound that blocks the spread of pancreatic and other cancers in various animal models. When cancer spreads from one part of the body to another in a process called metastasis, it can eventually grow beyond the reach of effective therapies. Now, there is a new plan of attack against this deadly process, thanks to scientists at the National Institutes of Health, Northwestern University and their collaborative research partners. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - May 16, 2018 Category: Cancer & Oncology Source Type: news

A 'dirty bomb' battles cancer metastasis
(Northwestern University) Scientists have developed a new compound that inhibits the spread of cancer cells, which is what makes the disease so lethal. The compound, metarrestin, significantly reduced metastasis by human prostate, pancreatic and breast cancer transplanted into mice. Mice treated with it had fewer metastatic tumors and lived longer than mice that did not receive treatment. Metarrestin is being submitted to the FDA as an investigational drug. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - May 16, 2018 Category: Cancer & Oncology Source Type: news

Former Nevada Sen. Harry Reid undergoes surgery for cancer
Former Nevada Sen. Harry Reid is recovering after undergoing surgery Monday to remove a cancerous tumor from his pancreas. The 78-year-old Reid will undergo chemotherapy. (Source: the Mail online | Health)
Source: the Mail online | Health - May 14, 2018 Category: Consumer Health News Source Type: news

New 'Scoring' System for Advanced Colorectal Cancer
(Johns Hopkins Medicine) Georgios Margonis, M.D., Ph.D., a surgical oncology fellow at the Johns Hopkins University School of Medicine, and Matthew Weiss, M.D., surgical director of the Johns Hopkins Liver and Pancreas Cancer Multidisciplinary Clinics, report advances in efforts to improve the treatment and prognosis of colorectal cancers that have spread to the liver. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - May 14, 2018 Category: International Medicine & Public Health Source Type: news

Pancreatic cancer: Weight loss and combating diabetes can reduce your risk
PANCREATIC cancer symptoms include stomach and back pain, nausea and blood clots. For diabetes type 2 sufferers, they are at greater risk of developing the condition owing to their symptoms. You should do this to lower your risk. (Source: Daily Express - Health)
Source: Daily Express - Health - May 12, 2018 Category: Consumer Health News Source Type: news

Hope for pancreatic cancer treatment as scientists slow down the tumours with gene editing
Researchers at Imperial College London found removing aggressive molecules called microRNAs  from mouse DNA slowed down the growth of tumours and weakened cancer cells. (Source: the Mail online | Health)
Source: the Mail online | Health - May 11, 2018 Category: Consumer Health News Source Type: news

Interpace Diagnostics Announces Expanded Coverage Among Blue Cross Blue Shield Plans
14 New Plans Cover ThyGenX® and ThyraMIR® in 2018 to Date PARSIPPANY, N.J., May 10, 2018 -- (Healthcare Sales & Marketing Network) -- Interpace Diagnostics Group, Inc. (NASDAQ:IDXG) (“Interpace” or “the Company”), a fully integrated commercial a... Diagnostics, Oncology, Reimbursement Interpace Diagnostics, ThyraMir, thyroid cancer, PancraGEN, pancreatic cancer (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - May 10, 2018 Category: Pharmaceuticals Source Type: news

Pancreatic cancer breakthrough: New treatment hope for fifth biggest cancer killer in UK
PANCREATIC cancer symptoms include stomach pain, weight loss and nausea or vomiting. It affects the pancreas, which produces the hormone insulin that regulates blood sugar levels. The fifth biggest cancer in the UK, scientists have just discovered a way to slow the condition. (Source: Daily Express - Health)
Source: Daily Express - Health - May 10, 2018 Category: Consumer Health News Source Type: news

Theranostic approach could aid pancreatic cancer patients
German researchers obtained positive results with a novel diagnostic and therapeutic...Read more on AuntMinnie.comRelated Reading: SNMMI: Theranostic agent targets pancreatic cancer (Source: AuntMinnie.com Headlines)
Source: AuntMinnie.com Headlines - May 3, 2018 Category: Radiology Source Type: news

Fibroblast Compression and Tumor Cells Migration
Role of Compression in MetastasisOurHuman Pancreatic Fibroblasts play a key role in this study.Pancreatic fibroblasts are continuously gaining ground as an important component of tumor microenvironment that dynamically interact with cancer cells to promote tumor progression. In addition, these tumor-infiltrated fibroblasts can acquire an activated phenotype and produce excessive amounts of extracellu lar matrix creating a highly dense stroma, a situation known as desmoplasia. Maria Kalli, Panagiotis Papageorgis, Vasiliki Gkretsi, Triantafyllos Stylianopoulos. (2018).Solid Stress Facilitates Fibroblasts Activation to Pro...
Source: Neuromics - May 1, 2018 Category: Neuroscience Tags: Cancer Associated Fibroblasts Desmoplasia Human Pancreatic Fibroblasts metastasis Source Type: news

Pancreatic Cancer, the Silent Disease
Title: Pancreatic Cancer, the Silent DiseaseCategory: Doctor's& Expert's views on SymptomsCreated: 11/1/2007 12:00:00 AMLast Editorial Review: 5/1/2018 12:00:00 AM (Source: MedicineNet Cancer General)
Source: MedicineNet Cancer General - May 1, 2018 Category: Cancer & Oncology Source Type: news

Florida Cancer Centers awarded $1.36 million to fight pancreatic cancer
(H. Lee Moffitt Cancer Center& Research Institute) The Florida Department of Health's James and Esther King Biomedical Research Program has armed Moffitt Cancer Center, University of Florida (UF) Health Cancer Center - Gainesville, Sylvester Comprehensive Cancer Center at the University of Miami and numerous collaborating centers with $1.36 million to address cancer disparities and improve outcomes and care for individuals affected by pancreatic cancer. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - May 1, 2018 Category: International Medicine & Public Health Source Type: news

Novel theranostic approach for treating pancreatic cancer patients shows promise
(Society of Nuclear Medicine and Molecular Imaging) German researchers have developed a novel diagnostic and therapeutic (theranostic) procedure for patients with ductal pancreatic adenocarcinoma, a deadly cancer with an extremely poor prognosis (five-year survival rate of less than 5 percent) and limited treatment options. The study is featured in the May issue of The Journal of Nuclear Medicine. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - May 1, 2018 Category: Cancer & Oncology Source Type: news

Saint Luke ’s Cancer Institute Awarded National Pancreatic Cancer...
SLCI is one of only 36 centers in the nation to achieve this designation(PRWeb May 01, 2018)Read the full story at http://www.prweb.com/releases/2018/05/prweb15455265.htm (Source: PRWeb: Medical Pharmaceuticals)
Source: PRWeb: Medical Pharmaceuticals - May 1, 2018 Category: Pharmaceuticals Source Type: news

What Causes Flushing?
Discussion Flushing is usually thought of as a benign condition such as blushing, but can be quite irritating if it is frequent or persistent (i.e. menopausal hot flashes) or even pathologic (i.e. malignancy). “Flushing is a subjective and sensation of warmth that is accompanied by reddening of the skin anywhere on the body but favors the face, neck, and upper torso…. Flushing can be broadly divided into episodic or persistent. Episodic flashing is mediated by the release of endogenous vasoactive mediators or medications, while persistent flushing result in a fixed facial erythema with telangiectasias and cyan...
Source: PediatricEducation.org - April 30, 2018 Category: Pediatrics Authors: pediatriceducationmin Tags: Uncategorized Source Type: news

Incidental Pancreatic Cysts: Majority Don't Progress to Cancer Incidental Pancreatic Cysts: Majority Don't Progress to Cancer
Dr Lowenfels comments on a study suggesting that most pancreatic cysts are harmless incidental findings.Medscape General Surgery (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - April 27, 2018 Category: Consumer Health News Tags: General Surgery Viewpoint Source Type: news

Presence and amount of gut bacteria can predict how fast pancreatic cancer cells grow
(Natural News) Pancreatic ductal adenocarcinoma, or PDA, is the most common and by far the most lethal form of pancreatic cancer. Pancreapedia reports that it is extremely aggressive, and for most patients their only hope of survival hinges on the total surgical removal of the tumor. Unfortunately, such tumors cannot be removed in upwards of... (Source: NaturalNews.com)
Source: NaturalNews.com - April 25, 2018 Category: Consumer Health News Source Type: news

Heavy Drinking May Change the Bacteria In Your Mouth and Raise Gum Disease Risk
There’s still quite a bit scientists don’t know about the microbiome: the vast collection of microorganisms living within your body. What is becoming increasingly clear, however, is that your lifestyle habits, from the foods you eat to the medications you take, may influence these bacterial colonies. Even drinking seems to have an effect. A new study, published Tuesday in the journal Microbiome, finds that drinking alcohol may alter some of the approximately 700 types of bacteria in your mouth — and probably not for the better. The study finds that alcohol may give rise to strains of oral bacteria that ar...
Source: TIME: Health - April 24, 2018 Category: Consumer Health News Authors: Jamie Ducharme Tags: Uncategorized Diet/Nutrition healthytime onetime Source Type: news

Primary pancreatic organoid tumor models for high-throughput phenotypic drug screening
(SLAS (Society for Laboratory Automation and Screening)) A multidisciplinary team of scientists share recent advancements in innovative in-vitro cancer biology methods for screening drug-like molecules in cancer tissue relevant models in a new report published online ahead-of-print at SLAS Discovery. Entitled Advanced Development of Primary Pancreatic Organoid Tumor Models for High-Throughput Phenotypic Drug Screening, the report can be accessed for free. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - April 20, 2018 Category: Cancer & Oncology Source Type: news

Medical News Today: Pancreatic cancer: Some blood pressure drugs put women at risk
A new study reveals that certain blood pressure drugs are linked with a high risk of pancreatic cancer among postmenopausal women. (Source: Health News from Medical News Today)
Source: Health News from Medical News Today - April 19, 2018 Category: Consumer Health News Tags: Pancreatic Cancer Source Type: news

Inhibit CXCR4 to Treat CRC and Pancreatic Cancer
In this video, Dr. Douglas Fearon outlines ways that inhibiting CXCR4 may provoke an immune response to treat pancreatic and colorectal cancer. (Source: CancerNetwork)
Source: CancerNetwork - April 18, 2018 Category: Cancer & Oncology Authors: Douglas T. Fearon, MD Tags: Conferences/AACR Street Team Colorectal Cancer Gastrointestinal Cancer News Source Type: news

Some Blood Pressure Meds Tied to Pancreatic Cancer Risk in Women
Title: Some Blood Pressure Meds Tied to Pancreatic Cancer Risk in WomenCategory: Health NewsCreated: 4/17/2018 12:00:00 AMLast Editorial Review: 4/18/2018 12:00:00 AM (Source: MedicineNet Cancer General)
Source: MedicineNet Cancer General - April 18, 2018 Category: Cancer & Oncology Source Type: news

Attention women: Your choice of blood pressure medicine may affect your risk of pancreatic cancer
In findings with potentially broad implications for the public ’s health, new research has found that some women who treat their high blood pressure with a class of drugs that relaxes the blood vessels were more likely to develop pancreatic cancer than those who use other hypertension medications.... (Source: Los Angeles Times - Science)
Source: Los Angeles Times - Science - April 18, 2018 Category: Science Authors: Melissa Healy Source Type: news

Short-Acting CCBs May Increase Risk of Pancreatic Cancer
Previous studies found calcium channel blockers could prevent pancreatic cancer, but have neglected to consider the effects of short-acting CCBs. (Source: CancerNetwork)
Source: CancerNetwork - April 17, 2018 Category: Cancer & Oncology Authors: Dave Levitan Tags: Gastrointestinal Cancer News Pancreatic Cancer Source Type: news

BP Meds Tied to Pancreatic Cancer Risk in Women
In a large study of postmenopausal women, those who had ever taken a short-acting calcium channel blocker (CCB) saw their pancreatic cancer risk shoot up by 66 percent. (Source: WebMD Health)
Source: WebMD Health - April 17, 2018 Category: Consumer Health News Source Type: news

Calcium Channel Blockers May Up Pancreatic Cancer Risk in Women
TUESDAY, April 17, 2018 -- Use of short-acting calcium channel blockers (CCBs) is associated with increased risk of pancreatic cancer in postmenopausal women, according to a study presented at the annual meeting of the American Association for... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - April 17, 2018 Category: Pharmaceuticals Source Type: news

Calcium Channel Blockers, A Type of Blood Pressure Med, Tied to Pancreatic Cancer Risk in Women
TUESDAY, April 17, 2018 -- Certain drugs prescribed to treat high blood pressure may boost a woman's risk for developing pancreatic cancer after menopause, new research suggests. In a large study of postmenopausal women, those who had ever taken a... (Source: Drugs.com - Daily MedNews)
Source: Drugs.com - Daily MedNews - April 17, 2018 Category: General Medicine Source Type: news

Latest Mesothelioma Immunotherapy Combination Looks Promising
Scientists at the Vaccine and Immunotherapy Center (VIC) at Massachusetts General Hospital have uncovered a novel, two-agent immunotherapy combination that worked surprisingly well in animal models with malignant mesothelioma. The discovery has sparked new optimism for immunotherapy, which has struggled to provide consistently positive results with aggressive cancers such as mesothelioma. “This is the beginning of a new story of hope, a new combination of immunotherapy,” Dr. Mark Poznansky, director of the VIC and associate professor at Harvard Medical School, told Asbestos.com. “It worked quite well in a...
Source: Asbestos and Mesothelioma News - April 17, 2018 Category: Environmental Health Authors: Daniel King Source Type: news

Abramson Cancer Canter studies show promise of immunotherapy combinations, including CAR T
(University of Pennsylvania School of Medicine) As immunotherapies continue to make up a larger share of new cancer drugs, researchers are looking for the most effective ways to use these cutting edge treatments in combination with each or with other pre-existing options. New studies from the Abramson Cancer Center are providing clues on potentially effective combinations with CAR T therapy in brain cancer as well as a novel therapeutic target in head and neck cancer, and also providing greater understanding of the mechanisms of resistance in pancreatic cancer. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - April 17, 2018 Category: Cancer & Oncology Source Type: news

Some Blood Pressure Meds Tied to Pancreatic Cancer Risk in Women
(Source: Cancercompass News: Other Cancer)
Source: Cancercompass News: Other Cancer - April 17, 2018 Category: Cancer & Oncology Source Type: news

Carpe Dia, Or My Treatment For Alzheimer's Disease
I ’m envious. My medical school classmate, climbed a mountain with his patient, and not just any mountain. Dr. Bilimoria and Ken Brown, a survivor of pancreatic cancer, ascended Mount Kilimanjaro. I’m envious because none of my patients survives Alzheimer's disease. So what do I have to offer them? (Source: Forbes.com Healthcare News)
Source: Forbes.com Healthcare News - April 15, 2018 Category: Pharmaceuticals Authors: Jason Karlawish, Contributor Source Type: news

Announcing the Pancreatic Cancer Collective
(Entertainment Industry Foundation) Lustgarten Foundation and SU2C announce the launch of the Pancreatic Cancer Collective, a formal strategic partnership to drive research to improve outcomes for pancreatic cancer patients. The Collective will leverage AI and machine learning; engage thought leaders; support the next gen of researchers; all to accelerate research and to develop new/better diagnoses and treatments. The initial funding commitment will be $25 million. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - April 15, 2018 Category: Cancer & Oncology Source Type: news

The Medical Device Behind the Discovery of a New Human Structure
What on Earth is this thing? That is the question David Carr-Locke, MD, and his colleagues asked when they discovered a microanatomical network of interconnected spaces, filled with fluid and lined by collagen with a unique arrangement, that appears to be present throughout the body. Whether or not this network is actually a newly discovered human organ is debatable. What is clear, however, is that this discovery is very widespread throughout the body and contains a lot of fluid, said Carr-Locke, clinical director of the Center for Advanced Digestive Care at Weill Cornell Medical College and New York Presbyterian...
Source: MDDI - April 13, 2018 Category: Medical Devices Authors: Amanda Pedersen Tags: Imaging Source Type: news

Booklet to help nurses with end of life care for pancreatic cancer
A new booklet on end of life care in pancreatic cancer has been launched with the aim of helping nurse and other healthcare professionals to support patients and their loved ones. (Source: Nursing Times)
Source: Nursing Times - April 13, 2018 Category: Nursing Source Type: news

To starve pancreatic tumors, researchers seek to block 'self-eating,' other fuel sources
(UNC Lineberger Comprehensive Cancer Center) UNC Lineberger Comprehensive Cancer Center researchers and their collaborators are reporting preclinical findings for a potential two-treatment strategy to block multiple mechanisms of cancer cell metabolism in pancreatic cancer at the American Association for Cancer Research Annual Meeting in Chicago. The findings will be presented from 8 a.m. to noon on Wednesday. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - April 13, 2018 Category: Cancer & Oncology Source Type: news

Lifestyle changes for men can lower cancer risk
Viewpoint Dr. Otis W. Brawley, Master of the American College of Physicians, is the chief medical and scientific officer for the Atlanta-based American Cancer Society. Cancer is the second-leading cause of death in American men, right behind heart disease. In 2018, four cancers are expected to account for half of all cancer deaths in American men: lung, with an estimated 83,600 deaths; prostate, with 29,400; colorectal, with 27,400; and pancreatic, with 23,000. The good news is that men can lower… (Source: bizjournals.com Health Care:Biotechnology headlines)
Source: bizjournals.com Health Care:Biotechnology headlines - April 9, 2018 Category: Biotechnology Source Type: news

£ 1 million funds 7 grants for pancreatic cancer research
(Pancreatic Cancer Research Fund) Seven research projects have been awarded grants totaling £ 1.1 million by the UK medical research charity, Pancreatic Cancer Research Fund (PCRF). The grants bring the charity's total research support to £ 10 million. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - April 6, 2018 Category: International Medicine & Public Health Source Type: news

Injecting gene cocktail into mouse pancreas leads to humanlike tumors
(University of Texas Health Science Center at San Antonio) A researcher at UT Health San Antonio (The University of Texas Health Science Center at San Antonio) has invented a unique method to generate, in mice, pancreatic tumors that resemble human pancreatic cancer. This will be a tool researchers can use to develop new drugs that extend patients' lives, and it is a tool researchers have not had at their disposal before. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - April 5, 2018 Category: International Medicine & Public Health Source Type: news

Mesothelioma Clinical Trial Opens with Optimism in South Florida
Dr. Chukwuemeka Ikpeazu at the Sylvester Comprehensive Cancer Center has brought hope — where once there was none — to patients in South Florida with unresectable pleural mesothelioma. Ikpeazu is the principal investigator in the multicenter phase II clinical trial involving the much-anticipated immunotherapy drug durvalumab. Pharmaceutical giant AstraZeneca manufactures the drug under the brand name Imfinzi. “I am optimistic, very, very optimistic that this drug will be effective for these patients,” Ikpeazu told Asbestos.com. “All the data, all the earlier studies, are encouraging.” He...
Source: Asbestos and Mesothelioma News - April 4, 2018 Category: Environmental Health Authors: Daniel King Source Type: news